Erk1/2 posphorylation site specific antibody
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 5, 2014
Grant Date -
Nov 10, 2011
app pub date -
Nov 26, 2009
filing date -
Nov 26, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to an antibody specific to Erk1/2 phosphorylated at Thr188 and a method for producing the same. The invention also relates to an in vitro method for determining the presence of phosphorylated Erk1/2 in a sample using the antibody of the invention. Therefore, the invention also comprises an assay for diagnosing a heart disease in vitro comprising the antibody of the invention and certain uses of the antibody. Moreover the invention relates to a peptide used to produce the antibody.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully